These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21538117)

  • 1. The neurobiology of erythropoietin.
    Sytkowski AJ
    Cell Mol Neurobiol; 2011 Aug; 31(6):931-7. PubMed ID: 21538117
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. A boost for translational neuroscience.
    Ehrenreich H
    Science; 2004 Jul; 305(5681):184-5. PubMed ID: 15247460
    [No Abstract]   [Full Text] [Related]  

  • 3. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
    Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
    Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategy of erythropoietin in neurological disorders.
    Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen actions in the nervous system: Complexity and clinical implications.
    Cersosimo MG; Benarroch EE
    Neurology; 2015 Jul; 85(3):263-73. PubMed ID: 26109716
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurovascular protection by erythropoietin: from the bedside back to the bench.
    Tufekci KU; Genc K
    Stroke; 2010 Jul; 41(7):e462. PubMed ID: 20466988
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin regulates signaling pathways associated with neuroprotective events.
    Sergio CM; Rolando CA
    Exp Brain Res; 2022 May; 240(5):1303-1315. PubMed ID: 35234993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
    Juul S
    Acta Paediatr Suppl; 2002; 91(438):36-42. PubMed ID: 12477263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin--a novel concept for neuroprotection.
    Sirén AL; Ehrenreich H
    Eur Arch Psychiatry Clin Neurosci; 2001 Aug; 251(4):179-84. PubMed ID: 11697582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of epoetin alfa on the central nervous system.
    Cerami A; Brines ML; Ghezzi P; Cerami CJ
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):66-70. PubMed ID: 11395856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and erythropoietin receptor in the developing human central nervous system.
    Juul SE; Anderson DK; Li Y; Christensen RD
    Pediatr Res; 1998 Jan; 43(1):40-9. PubMed ID: 9432111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some aspects of pleiotropic activity of erythropoietin].
    Switalski M; Małecki R
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():81-8. PubMed ID: 15669205
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin update 2011.
    Kowalczyk M; Banach M; Mikhailidis DP; Rysz J
    Med Sci Monit; 2011 Nov; 17(11):RA240-247. PubMed ID: 22037755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of the cannabinoids in neuroprotection.
    Grundy RI
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1365-74. PubMed ID: 12387700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.
    Pankratova S; Kiryushko D; Sonn K; Soroka V; Køhler LB; Rathje M; Gu B; Gotfryd K; Clausen O; Zharkovsky A; Bock E; Berezin V
    Brain; 2010 Aug; 133(Pt 8):2281-94. PubMed ID: 20435631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
    Juul S
    Clin Perinatol; 2004 Mar; 31(1):129-42. PubMed ID: 15183662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin for neonatal brain injury: opportunity and challenge.
    Xiong T; Qu Y; Mu D; Ferriero D
    Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
    Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
    Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.